Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

[1]  M. Bessler,et al.  Prospective Study of Gut Hormone and Metabolic Changes After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass , 2009, International Journal of Obesity.

[2]  A. Lacy,et al.  Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  S. Salinari,et al.  First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery , 2009, Diabetes Care.

[4]  D. Zheng,et al.  Mechanism for improved insulin sensitivity after gastric bypass surgery. , 2008, The Journal of clinical endocrinology and metabolism.

[5]  B. Viollet,et al.  Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. , 2008, Cell metabolism.

[6]  A. Kotronen,et al.  Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. , 2008, Gastroenterology.

[7]  J. Kullberg,et al.  Lipid Mobilization Following Roux-en-Y Gastric Bypass Examined by Magnetic Resonance Imaging and Spectroscopy , 2008, Obesity surgery.

[8]  Mark Ellrichmann,et al.  Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance , 2008, Diabetes.

[9]  Margaret Anderson,et al.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.

[10]  Daniel B. Jones,et al.  Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  A. Baltasar,et al.  Critical assessment of the current guidelines for the management and treatment of morbidly obese patients , 2007, Journal of endocrinological investigation.

[12]  J. Holst,et al.  Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[13]  F. Middleton,et al.  Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  J. Marescaux,et al.  The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes , 2006, Annals of surgery.

[15]  O. Kaidar-Person,et al.  Laparoscopic Sleeve Gastrectomy as Treatment for Morbid Obesity: Technique and Short-Term Outcome , 2006, Obesity surgery.

[16]  M. Bessler,et al.  Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels , 2006, Obesity.

[17]  A. Mari,et al.  Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.

[18]  C. Thompson,et al.  The Early Effects of Weight Loss Surgery on Regional Adiposity , 2005, Obesity surgery.

[19]  J. Dixon,et al.  A Prospective Randomized Trial of Placement of the Laparoscopic Adjustable Gastric Band: Comparison of the Perigastric and Pars Flaccida Pathways , 2005, Obesity surgery.

[20]  G. Tsujimoto,et al.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.

[21]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[22]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[23]  M. Gagner,et al.  The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism , 2004, Annals of surgery.

[24]  R. DeFronzo,et al.  Pathogenesis of type 2 diabetes mellitus. , 2004, The Medical clinics of North America.

[25]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[26]  R. Unger.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .

[27]  L. Kuller,et al.  Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus , 2003 .

[28]  T. Alexandrides,et al.  Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. , 2003, Diabetes.

[29]  M. Matsuda,et al.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study , 2003, Diabetologia.

[30]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[31]  G. Mingrone,et al.  Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids , 1997, Diabetologia.

[32]  W. Pories,et al.  Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.

[33]  K. Polonsky,et al.  Alterations in Immunoreactive Proinsulin and Insulin Clearance Induced by Weight Loss in NIDDM , 1994, Diabetes.

[34]  W. Kohrt,et al.  Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. , 1993, Journal of gerontology.

[35]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[36]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.